Wednesday, July 8, 2026

pharma · Cholestatic liver disease · Cystic Fibrosis · PRQR

ProQR Therapeutics N.V

ProQR Therapeutics N.V trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Leiden, NL HQ
2012 Founded
204 Employees
Public company Type
PRQR · NYSE Ticker
Company details
Status
Public
HQ
Leiden, NL
Founded
2012
Employees
204
Programs
6
Drugs
2
Patents
19
Intelligence · Clinical Trials

ProQR Therapeutics N.V clinical trials

Registry index of 8 ClinicalTrials.gov studies linked to ProQR Therapeutics N.V programs — each row shows trial ID, program name, phase, status, and indication.

ProQR Therapeutics N.V trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for ProQR Therapeutics N.V.

  1. PQ-0810-001 — Phase 1

    Clinical update
  2. QR-504a — Phase 1

    Clinical update
  3. QR-1123 — Phase 2

    Clinical update
  4. sepofarsen — Phase 3

    Clinical update
  5. QR-010 — Phase 2

    Clinical update
  6. QR-421a — Phase 2

    Clinical update

Trial registry

8 studies